Abbott announced today that it has updated NeuroSphere, its app-driven neuromodulation therapy platform, with remote programming capabilities that will allow patients to speak with and receive ...
ST. LOUIS, June 30, 2026 /PRNewswire/ -- Aurenar, developer of a non-invasive neuromodulation platform for patients in intensive care, today announced that the U.S. Food and Drug Administration (FDA) ...
Throughout my career, I have learned that the greatest impact of innovation comes not from adopting new technologies alone but from integrating them into clinical workflows that improve ...
My brain injury in 2000 affected my balance and gait. Doctors assessed it by asking me to walk across a small room and back again. Aside from that observational method, which would not have apprised ...
DUBLIN, March 24, 2022 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the first patient implants in the TITAN 2 pivotal study that will evaluate ...
PARK CITY, Utah--(BUSINESS WIRE)--BlueWind Medical, Ltd., a leader in implantable Tibial Neuromodulation (iTNM) and developer of the Revi® System, a patient-centric solution for urge urinary ...
New Investigational Device Aims to Expand Access to Therapy for Patients with Incontinence; Underscores Medtronic's Leadership as Only Company to Offer Neuromodulation Options for Incontinence DUBLIN, ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sinaptica Therapeutics, Inc., a clinical-stage company leading the development of a new class of personalized neuromodulation therapeutics to treat Alzheimer’s and ...
Israeli-based digital health technology company GrayMatters Health, which develops self-neuromodulation therapies for mental disorders, received FDA 510(k) clearance for its PTSD-focused ...
A new review study looking at the current state of neuromodulation therapies being used to treat depression, including rTMS, ECT and others, is available online today in the December issue of The ...
Credit: Getty Images. Primary care is the predominant site for migraine consultation and management for 70.3% of patients. A 46-year-old Black woman presents with a history of migraines since age 13.
A new type of magnetic brain stimulation brought rapid remission to almost 80% of participants with severe depression in a study conducted at the Stanford University School of Medicine. The treatment, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results